Genelux (GNLX) Tax Provisions (2022)

Genelux's (GNLX) quarterly Tax Provisions came in at $1.1 million in Q3 2022.

Genelux (GNLX) Tax Provisions (2022) Analysis & Trends

Genelux's Tax Provisions history runs 1 years deep, the most recent figure standing at $1.1 million for Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 66,741.39 Bn 66,741.11 Bn - 125,146.46
2 Nanobiotix 1,935.05 Bn 1,934.98 Bn - -
3 Akari Therapeutics 1,045.06 Bn 1,045.06 Bn - -859,000.00
4 BeOne Medicines 468.98 Bn 464.19 Bn 1.35 Bn 31.86 Mn
5 Vertex Pharmaceuticals 123.24 Bn 115.99 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 70.45 Bn 61.70 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 63.04 Bn 63.04 Bn - -
8 Argenx Se 55.79 Bn 50.60 Bn 1.41 Bn 179.00 Mn
9 Alnylam Pharmaceuticals 37.79 Bn 34.78 Bn 959.66 Mn 15.66 Mn
10 Genelux 129.36 Mn 129.36 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 1.10 Mn